About Arbutus
Specialized in virology. Focused on growth.
We are a clinical-stage biopharmaceutical company with deep virology expertise and an unwavering focus on curing conditions with unmet medical need. Today, we’re drawing upon our understanding and expertise in treating viral infections with our novel therapeutics focused on hepatitis B virus (HBV).
What makes us different?
Multi-faceted, unique mechanisms of action.
We are focused on the development of combination drugs to attack HBV through multiple mechanisms of action to significantly improve treatment options and outcomes for patients.
Active clinical trials.
Our pipeline includes clinical trials spanning combination therapies with diverse routes of administration.
Tenacious and highly experienced team.
The members of our leadership team have successful track records in the discovery, development, and commercialization of several widely recognized antivirals.
Why Arbutus?
The meaning behind our name.
Arbutus is a plant found throughout North America, where we are headquartered, that is known to have healing properties. Much like our botanical namesake, we are mutually focused on the growth of our portfolio of therapeutics and the healing of the patients who suffer from our targeted conditions.
